These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 23800185

  • 1. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
    Hegyi V, Petrovajová M, Novotný M.
    Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
    [Abstract] [Full Text] [Related]

  • 2. Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model.
    Hamzavi I, Shiff N, Martinka M, Huang Z, McLean D, Zeng H, Lui H.
    Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):46-51. PubMed ID: 16436181
    [Abstract] [Full Text] [Related]

  • 3. Objective determination of skin phototypes in healthy children by diffuse reflectance spectroscopy.
    Petrovajova M, Carska N, Novotny M.
    Bratisl Lek Listy; 2014 Feb; 115(12):791-5. PubMed ID: 25520230
    [Abstract] [Full Text] [Related]

  • 4. Monte Carlo simulation of cutaneous reflectance and fluorescence measurements--the effect of melanin contents and localization.
    Chen R, Huang Z, Lui H, Hamzavi I, McLean DI, Xie S, Zeng H.
    J Photochem Photobiol B; 2007 Mar 01; 86(3):219-26. PubMed ID: 17157523
    [Abstract] [Full Text] [Related]

  • 5. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
    Westerhof W, Nieuweboer-Krobotova L.
    Arch Dermatol; 1997 Dec 01; 133(12):1525-8. PubMed ID: 9420536
    [Abstract] [Full Text] [Related]

  • 6. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D, Kanwar AJ, Kumar B.
    J Eur Acad Dermatol Venereol; 2006 Feb 01; 20(2):175-7. PubMed ID: 16441626
    [Abstract] [Full Text] [Related]

  • 7. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
    Kollias N, Baqer A, Sadiq I.
    Photodermatol Photoimmunol Photomed; 1994 Dec 01; 10(6):249-54. PubMed ID: 7727281
    [Abstract] [Full Text] [Related]

  • 8. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A, Kanwar AJ, Parsad D, De D.
    J Eur Acad Dermatol Venereol; 2007 Nov 01; 21(10):1381-5. PubMed ID: 17958845
    [Abstract] [Full Text] [Related]

  • 9. Spectroscopic characteristics of human melanin in vivo.
    Kollias N, Baqer A.
    J Invest Dermatol; 1985 Jul 01; 85(1):38-42. PubMed ID: 4008975
    [Abstract] [Full Text] [Related]

  • 10. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
    Sapam R, Agrawal S, Dhali TK.
    Int J Dermatol; 2012 Sep 01; 51(9):1107-15. PubMed ID: 22909369
    [Abstract] [Full Text] [Related]

  • 11. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS, Palmer RA, Garibaldinos TM, Hawk JL.
    Arch Dermatol; 2007 May 01; 143(5):578-84. PubMed ID: 17519217
    [Abstract] [Full Text] [Related]

  • 12. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
    Anbar TS, El-Sawy AE, Attia SK, Barakat MT, Moftah NH, El-Ammawy TS, Abdel-Rahman AT, El-Tonsy MH.
    Photodermatol Photoimmunol Photomed; 2012 Feb 01; 28(1):17-25. PubMed ID: 22211999
    [Abstract] [Full Text] [Related]

  • 13. Effect of PUVA therapy on electrodermal activity parameters in vitiligo patients.
    Dolu N, Ferahbaş A, Ozesmi C, Peker D, Açik C.
    Auton Neurosci; 2005 Mar 31; 118(1-2):102-7. PubMed ID: 15795183
    [Abstract] [Full Text] [Related]

  • 14. The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA.
    Akyol M, Celik VK, Ozcelik S, Polat M, Marufihah M, Atalay A.
    Eur J Dermatol; 2002 Mar 31; 12(1):24-6. PubMed ID: 11809591
    [Abstract] [Full Text] [Related]

  • 15. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA, Rogers S.
    Clin Exp Dermatol; 1996 Jan 31; 21(1):43-5. PubMed ID: 8689768
    [Abstract] [Full Text] [Related]

  • 16. Topical Histamine Stimulates Repigmentation of Nonsegmental Vitiligo by a Receptor-Dependent Mechanism.
    Liu J, Xu Y, Lin TK, Lv C, Elias PM, Man MQ.
    Skin Pharmacol Physiol; 2017 Jan 31; 30(3):139-145. PubMed ID: 28419984
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M, Saedi K.
    J Dermatolog Treat; 2006 Jan 31; 17(3):151-3. PubMed ID: 16854754
    [Abstract] [Full Text] [Related]

  • 19. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E, Ziv M, Rosenman D, David M.
    Harefuah; 2006 Jul 31; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.